Lumexa Imaging Holdings, Inc. (LMRI) Stock Analysis
Healthcare · Medical Devices
Hold if already holding. Not a fresh buy at $8.65, but acceptable to hold if already in. Reason: Market cap $0.78B below $1B minimum.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well... Read more
Hold if already holding. Not a fresh buy at $8.65, but acceptable to hold if already in. Reason: Market cap $0.78B below $1B minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $0.78B below $1B minimum. Not in investable universe. Score 4.8/10, moderate confidence.
Passes 8/8 gates (positive momentum, favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 65d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent developments
updated 2026-06-09Recent Developments — Lumexa Imaging Holdings, Inc.
Latest news
- NEWS Lumexa Imaging Forms Strategic JV With Hospital For Special Surgery To Expand Access To Advanced Outpatient Imaging Serv — benzinga Jun 2, 2026
- NEWS Barclays Maintains Overweight on Lumexa Imaging Hldgs, Lowers Price Target to $9 — benzinga May 20, 2026
- NEWS 12 Health Care Stocks Moving In Wednesday's Intraday Session — benzinga May 13, 2026
- NEWS Lumexa Imaging Holdings Q1 2026 Earnings Call Transcript — benzinga May 12, 2026
- NEWS Lumexa Imaging Holdings Sees FY2026 Adj EPS $0.71-$0.77 vs $0.73 Est; Narrows FY2026 Sales Guidance from $1.045B-$1.097B — benzinga May 12, 2026
Generated 2026-06-15T18:11:46Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
5 floor-breakers
Unprofitable operations — net margin -3.7%. Quality floor flags this regardless of sector context.static
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static
Growth below the gate floor. Component breakdown shows what dragged the score down.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $8.65, but acceptable to hold if already in. Reason: Market cap $0.78B below $1B minimum. Chart setup: No clear chart pattern; technical signals are mixed. Market cap $0.78B below $1B minimum. Not in investable universe. Target $15.04 (+73.9%), stop $8.04 (−7.6%), A.R:R 4.9:1. Score 4.8/10, moderate confidence.
Take-profit target: $15.04 (+73.9% upside). Target $15.04 (+73.9%), stop $8.04 (−7.6%), A.R:R 4.9:1. Stop-loss: $8.04.
Market cap $0.78B below $1B minimum.
Lumexa Imaging Holdings, Inc. trades at a P/E of N/A (forward 9.1). TrendMatrix value score: 7.7/10. Verdict: Hold.
14 analysts cover LMRI with a consensus score of 4.4/5. Average price target: $17.
What does Lumexa Imaging Holdings, Inc. do?Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides...
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.